Key result
Anticoagulation with vitamin K antagonists allowed a relatively safe control of both thrombotic and bleeding issues, leading to a partial reduction in mass dimension without further embolic or hemorrhagic events at 1 month.
Why the study?
Thrombosis after transvenous lead placement is underestimated and often clinically silent, with no clinical guidelines or clear evidence regarding optimal treatment.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Vitamin K antagonists allowed relatively safe control of both thrombotic and bleeding issues in a frail elderly patient with pacemaker lead-related atrial thrombosis and pulmonary embolism.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pistelli et al. (2022) conducted a case report in Pacemaker lead-related atrial thrombosis (n=1). Vitamin K antagonists (VKA) was evaluated on Clinical improvement and reduction in mass dimension. Anticoagulation with vitamin K antagonists allowed a relatively safe control of both thrombotic and bleeding issues, leading to a partial reduction in mass dimension without further embolic or hemorrhagic events at 1 month.
Synapse has enriched 10 related papers. Consider them for comparative context: